CSL Behring

IDELVION

Manufacturer:

CSL Behring

Idelvion HCPCS:

J7202

HCPCS Code Descriptor:

Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.

Category:

J Code

Idelvion NDCs:

69911-0865-02, 69911-0867-02, 69911-0866-02, 69911-0864-02, 69911-0869-02

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Idelvion:

IDELVION is a Hematology drug manufactured by CSL Behring and administered via the Intravenous route of administration. The J Code: J7202 is aligned to the drug IDELVION.

ACCESS PRICING AND MORE BY REGISTERING

J7202 Added Date:

January 1, 2017

J7202 Effective Date:

January 1, 2017

J7202 Termination Date:

HCPCS Active

Idelvion billing and coding information can be found through Csl Behring at the link below:
Idelvion patient assistance information can be found through CSL Behring at the URL: https://www.cslbehring.com/patients/support-and-assistance
IDELVION prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for IDELVION. Please check back in a few weeks.